|
Jul 2
|
Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern
|
|
Jun 30
|
Changes to the Roche Enlarged Corporate Executive Committee
|
|
Jun 27
|
Initiation of commercialization of ProNephro AKI (NGAL) for diagnostic use in the US
|
|
Jun 26
|
Will MRK's Growing Pipeline Help Navigate the Looming Keytruda LOE?
|
|
Jun 26
|
Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025
|
|
May 7
|
SRPT Q1 Earnings Miss, Sales Beat, Stock Slides 21% on '25 View Cut
|
|
May 6
|
Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity
|
|
May 1
|
'Declare victory and move on': Eli Lilly CEO on Trump tariff threat
|
|
Apr 25
|
Roche’s diagnostic sales hit by China pricing reforms
|
|
Apr 25
|
New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission
|
|
Apr 24
|
Roche's Q1 Sales Increase Y/Y on Solid Performance of Key Drugs
|
|
Apr 24
|
Drugmakers brace for Trump tariffs, while weighing numerous other worries
|
|
Apr 24
|
Repertoire and Genentech to develop autoimmune disease therapies
|
|
Apr 24
|
Roche introduces algorithm for ACS detection in individuals with chest pain
|
|
Apr 24
|
Roche seeks US tariff relief in direct talks with Trump administration
|
|
Apr 24
|
Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push
|
|
Apr 24
|
Roche Q1 sales up 7% on drugs Phesgo, Vabysmo
|
|
Apr 24
|
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues good momentum into 2025 with 6% (CER) sales growth in the first quarter
|
|
Apr 23
|
Roche looks to a Flagship startup in search of new immune drugs
|
|
Apr 23
|
Switzerland flexes financial muscle ahead of tariff date in Washington
|